Skip to main content Skip to secondary navigation

Funding Opportunities

Main content start

Experimental Human Biology, Fall 2022

The IMA is accepting proposals to address unmet medical needs through human subjects research. Through this solicitation, the IMA seeks to support research projects aimed at testing hypotheses in human subjects that, if validated, have the potential to pave the road to new medicines, vaccines and diagnostics or to enhance clinical use of existing ones.

The purpose of this request for letters of intent (LOI) is to leverage the capacity and infrastructure at Stanford to address unmet medical needs through human subjects research. Competitive projects will have a strong mechanistic basis or empirical rationale and will utilize either the Stanford School of Medicine Clinical and Translational Research Unit (CTRU), or IMA COVID CTRU where patients can be safely tested and/or treated. Research on any indication, therapy, or disease including SARS-CoV2 or COVID-19 is eligible for support through this mechanism.

Letters of Intent must be received by December 16, 2022, 11:59pm.

Learn More